28.75
-0.35%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Apex Biotechnology
Its shares trade on Taiwan Stock Exchange under the ticker 1733.TW. It has been listed since 17 September 2001. In the fiscal year to 31 December 2025, it reported revenue of TWD 1.94bn and net income of TWD 163.0m. At that date it held total assets of TWD 2.42bn and shareholders' equity of TWD 1.87bn.
Apex Biotechnology Corp. engages in the research, development, manufacture and sell of biotechnological products. The company is headquartered in Hsinchu, Hsinchu. The company went IPO on 2001-09-17. The firm primarily provides testing strips and monitoring systems, including blood glucose monitoring systems, uric acid monitoring systems, pesticide residue detection systems, lactate monitoring systems and hemachrome testing systems, among others. Its blood glucose monitoring systems and uric acid monitoring systems are mainly used by patients, doctors and nurses in hospitals and clinics. The firm distributes its products in domestic market and to overseas markets, including the Americas, Europe and the rest of Asia.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 17 Sept 2001
- Website
- apexbio.com.tw ↗
Leadership
Pay as last reported
- Mr. Yanshi ShenChairman of the Board, General Manager, since 1997
- Mr. Yingxiang ZhuChief Financial Officer-Finance Division
- Mr. Mengwen YangDeputy General Manager-Manufacturing Division, Director, since 1997
- Ms. Chunhui WuDeputy General Manager-Management Division
- Mr. Chengyu ShenDeputy General Manager-Business Division
- Renhao TianDirector
- Mr. Zhengming BaiIndependent Director
- Mr. Jinchang BaoIndependent Director
- Ms. Yiyun ChiIndependent Director
- Mr. Yung-Lu TsaiIndependent Director
- Zhenyi WuIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Apex Biotechnology Corp possesses several strengths that contribute to its success in the market. Firstly, the company has a strong reputation for producing high-quality biotechnology products. This reputation has been built over years of delivering reliable solutions to its customers.
- Secondly, Apex Biotechnology Corp has a team of experienced and knowledgeable scientists and researchers. This expertise enables the company to stay at the forefront of biotechnological advancements and develop innovative products.
- Additionally, Apex Biotechnology Corp benefits from strong partnerships with leading institutions and organizations in the industry. These collaborations provide access to resources, facilities, and expertise that further enhance the company's competitive edge.
Weaknesses
- Despite its strengths, Apex Biotechnology Corp also faces certain weaknesses that could hinder its growth. One weakness is the relatively high production costs associated with biotechnology research and development. These costs can put strain on the company's financial resources.
- Another weakness is the company's limited market presence. Compared to some of its competitors, Apex Biotechnology Corp has a smaller customer base and lower brand recognition. This could impact its ability to compete effectively and expand its market share.
Opportunities
- There are several opportunities that Apex Biotechnology Corp can capitalize on to further its growth and profitability. Firstly, the increasing demand for biotechnology products and solutions presents a significant opportunity for the company to expand its market reach.
- Furthermore, advancements in technology and research offer the potential for Apex Biotechnology Corp to develop new and improved products. This could not only attract new customers but also strengthen relationships with existing ones.
- Additionally, partnerships and collaborations with pharmaceutical companies or academic institutions can open doors to explore new avenues and take advantage of synergies to drive innovation and commercial success.
Threats
- Apex Biotechnology Corp faces certain threats that could potentially impede its progress. One major threat is intense competition within the biotechnology industry. The presence of established and emerging players requires Apex Biotechnology Corp to continuously differentiate itself and stay ahead of the competition.
- Another threat is the regulatory environment surrounding biotechnology. Changes in regulations or unforeseen legal barriers could impact the development, production, and distribution of Apex Biotechnology Corp's products.
- Moreover, economic downturns or uncertainties can affect the overall demand for biotechnology solutions, potentially leading to a decline in sales for Apex Biotechnology Corp.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.